Medgenics, Inc. to Present at the Maxim Group Growth Conference
3/21/2012 8:03:33 AM
MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that Andrew L. Pearlman, Ph.D., President and Chief Executive Officer of Medgenics, will present a corporate overview and update at the Maxim Group Growth Conference being held on Monday, March 26, 2012 at The Grand Hyatt Hotel, Grand Central Station, New York. Dr. Pearlman will deliver his presentation on March 26 at 10:30 a.m. Eastern time.
comments powered by